Large B-Cell Lymphoma in an Adolescent Patient With Interleukin-10 Receptor Deficiency and History of Infantile Inflammatory Bowel Disease.
作者信息
Shouval Dror S, Ebens Christen L, Murchie Ryan, McCann Katelyn, Rabah Raja, Klein Christoph, Muise Aleixo M, Snapper Scott B
机构信息
*Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital †Department of Pediatrics ‡Department of Medicine, Harvard Medical School, Boston, MA §Division of Pediatric Hematology and Oncology ||Division of Pathology, University of Michigan, Ann Arbor, MI ¶SickKids Inflammatory Bowel Disease Center and Cell Biology Program, Research Institute #Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of Toronto, Hospital for Sick Children, Toronto, ON, Canada **Dr von Hauner Children's Hospital, Ludwig-Maximilians-University, Munich, Germany ††Division of Gastroenterology, Brigham and Women's Hospital ‡‡interNational Early Onset Paediatric IBD Cohort Study (NEOPICS), Boston, MA.
出版信息
J Pediatr Gastroenterol Nutr. 2016 Jul;63(1):e15-7. doi: 10.1097/MPG.0000000000000532.
Abstract
摘要
相似文献
1
Large B-Cell Lymphoma in an Adolescent Patient With Interleukin-10 Receptor Deficiency and History of Infantile Inflammatory Bowel Disease.
J Pediatr Gastroenterol Nutr. 2016 Jul;63(1):e15-7. doi: 10.1097/MPG.0000000000000532.
2
A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency.
Blood. 2013 Nov 28;122(23):3713-22. doi: 10.1182/blood-2013-06-508267. Epub 2013 Oct 2.
3
No immunosurveillance in human IL-10R deficiency.
Blood. 2013 Nov 28;122(23):3702-3. doi: 10.1182/blood-2013-10-531657.
4
Phenotypic Characterization of Very Early-Onset Inflammatory Bowel Disease with Interleukin-10 Signaling Deficiency: Based on a Large Cohort Study.
Inflamm Bowel Dis. 2019 Mar 14;25(4):756-766. doi: 10.1093/ibd/izy289.
5
Novel de novo mutations of the interleukin-10 receptor gene lead to infantile onset inflammatory bowel disease.
J Crohns Colitis. 2014 Nov;8(11):1551-6. doi: 10.1016/j.crohns.2014.04.004. Epub 2014 May 10.
6
Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy.
Gastroenterology. 2012 Aug;143(2):347-55. doi: 10.1053/j.gastro.2012.04.045. Epub 2012 Apr 28.
7
Development and Function of Immune Cells in an Adolescent Patient With a Deficiency in the Interleukin-10 Receptor.
J Pediatr Gastroenterol Nutr. 2017 Jul;65(1):e5-e15. doi: 10.1097/MPG.0000000000001559.
8
Umbilical Cord Blood Transplantation Corrects Very Early-Onset Inflammatory Bowel Disease in Chinese Patients With IL10RA-Associated Immune Deficiency.
Inflamm Bowel Dis. 2018 Jun 8;24(7):1416-1427. doi: 10.1093/ibd/izy028.
9
Novel de Novo Mutations of the Interleukin-10 Receptor Gene Lead to Infantile Onset Inflammatory Bowel Disease: A Correction.
J Crohns Colitis. 2017 Oct 27;11(11):1398-1399. doi: 10.1093/ecco-jcc/jjx038.
10
Interleukin-10 in inflammatory bowel disease.
N Engl J Med. 2009 Nov 19;361(21):2091-3. doi: 10.1056/NEJMe0909225. Epub 2009 Nov 4.
引用本文的文献
1
Very Early Onset of Fistulizing Inflammatory Bowel Disease With RIPK1 Mutation: A Case Report.
Cureus. 2024 Mar 7;16(3):e55708. doi: 10.7759/cureus.55708. eCollection 2024 Mar.
2
Hallmarks of Cancers: Primary Antibody Deficiency Other Inborn Errors of Immunity.
Front Immunol. 2021 Aug 17;12:720025. doi: 10.3389/fimmu.2021.720025. eCollection 2021.
3
Translating Treg Therapy for Inflammatory Bowel Disease in Humanized Mice.
Cells. 2021 Jul 21;10(8):1847. doi: 10.3390/cells10081847.
4
The Growing Need to Understand Very Early Onset Inflammatory Bowel Disease.
Front Immunol. 2021 May 26;12:675186. doi: 10.3389/fimmu.2021.675186. eCollection 2021.
5
Alterations in T and B Cell Receptor Repertoires Patterns in Patients With IL10 Signaling Defects and History of Infantile-Onset IBD.
Front Immunol. 2020 Feb 6;11:109. doi: 10.3389/fimmu.2020.00109. eCollection 2020.
6
Humanized mouse models of genetic immune disorders and hematological malignancies.
Biochem Pharmacol. 2020 Apr;174:113671. doi: 10.1016/j.bcp.2019.113671. Epub 2019 Oct 18.
7
A Systematic Review on Predisposition to Lymphoid (B and T cell) Neoplasias in Patients With Primary Immunodeficiencies and Immune Dysregulatory Disorders (Inborn Errors of Immunity).
Front Immunol. 2019 Apr 16;10:777. doi: 10.3389/fimmu.2019.00777. eCollection 2019.
8
The Treatment of Inflammatory Bowel Disease in Patients with Selected Primary Immunodeficiencies.
J Clin Immunol. 2018 Jul;38(5):579-588. doi: 10.1007/s10875-018-0524-9. Epub 2018 Jun 29.
9
Anti-inflammatory effects of administered as a potential drug for ulcerative colitis.
Exp Ther Med. 2017 Nov;14(5):4745-4754. doi: 10.3892/etm.2017.5153. Epub 2017 Sep 20.
10
Early Diagnosis and Hematopoietic Stem Cell Transplantation for IL10R Deficiency Leading to Very Early-Onset Inflammatory Bowel Disease Are Essential in Familial Cases.
Case Reports Immunol. 2016;2016:5459029. doi: 10.1155/2016/5459029. Epub 2016 Sep 6.
本文引用的文献
1
Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.
Clin Gastroenterol Hepatol. 2015 May;13(5):847-58.e4; quiz e48-50. doi: 10.1016/j.cgh.2014.05.015. Epub 2014 May 28.
2
Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function.
Immunity. 2014 May 15;40(5):706-19. doi: 10.1016/j.immuni.2014.03.011. Epub 2014 May 1.
3
Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans.
Adv Immunol. 2014;122:177-210. doi: 10.1016/B978-0-12-800267-4.00005-5.
4
Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-α therapy in inflammatory bowel disease.
Aliment Pharmacol Ther. 2014 Mar;39(5):447-58. doi: 10.1111/apt.12624. Epub 2014 Jan 20.
5
Phenotypic characterization of very early-onset IBD due to mutations in the IL10, IL10 receptor alpha or beta gene: a survey of the Genius Working Group.
Inflamm Bowel Dis. 2013 Dec;19(13):2820-8. doi: 10.1097/01.MIB.0000435439.22484.d3.
6
A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency.
Blood. 2013 Nov 28;122(23):3713-22. doi: 10.1182/blood-2013-06-508267. Epub 2013 Oct 2.
7
Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation.
J Allergy Clin Immunol. 2013 Mar;131(3):825-30. doi: 10.1016/j.jaci.2012.09.025. Epub 2012 Nov 14.
8
Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy.
Gastroenterology. 2012 Aug;143(2):347-55. doi: 10.1053/j.gastro.2012.04.045. Epub 2012 Apr 28.
9
IL-10 elicits IFNγ-dependent tumor immune surveillance.
Cancer Cell. 2011 Dec 13;20(6):781-96. doi: 10.1016/j.ccr.2011.11.003.
10
Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation.
J Clin Immunol. 2010 Nov;30(6):886-93. doi: 10.1007/s10875-010-9452-z. Epub 2010 Sep 22.
Zotero 插件